{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:21:38Z","timestamp":1792801298093,"version":"4.5.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T00:00:00Z","timestamp":1487548800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"name":"Donation to Golomb Research Group","award":["Dr. Murray Rosenthal"],"award-info":[{"award-number":["Dr. Murray Rosenthal"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Drug Saf - Case Rep"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1007\/s40800-017-0045-0","type":"journal-article","created":{"date-parts":[[2017,2,20]],"date-time":"2017-02-20T01:37:42Z","timestamp":1487554662000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Physicians\u2019 Experiences as Patients with Statin Side Effects: A Case Series"],"prefix":"10.1007","volume":"4","author":[{"given":"Hayley J.","family":"Koslik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athena Hathaway","family":"Meskimen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice Alexandra","family":"Golomb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,2,20]]},"reference":[{"key":"45_CR1","first-page":"493","volume":"104","author":"RS Scott","year":"1991","unstructured":"Scott RS, Lintott CJ, Wilson MJ. Simvastatin and side effects. N Z Med J. 1991;104:493\u20135.","journal-title":"N Z Med J"},{"key":"45_CR2","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s10557-005-5686-z","volume":"19","author":"E Bruckert","year":"2005","unstructured":"Bruckert E, Hayem G, Dejager S, Yau C, Begaud B. Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients\u2014the PRIMO study. Cardiovasc Drugs Ther. 2005;19:403\u201314.","journal-title":"Cardiovasc Drugs Ther"},{"key":"45_CR3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.2165\/00002018-200730080-00003","volume":"30","author":"BA Golomb","year":"2007","unstructured":"Golomb BA, McGraw JJ, Evans MA, Dimsdale JE. Physician response to patient reports of adverse drug effects: implications for patient-targeted adverse effect surveillance. Drug Saf. 2007;30:669\u201375.","journal-title":"Drug Saf"},{"key":"45_CR4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1592\/phco.30.6.541","volume":"30","author":"S Cham","year":"2010","unstructured":"Cham S, Evans MA, Denenberg JO, Golomb BA. Statin-associated muscle-related adverse effects: a case series of 354 patients. Pharmacotherapy. 2010;30:541\u201353.","journal-title":"Pharmacotherapy"},{"key":"45_CR5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.2165\/0129784-200808060-00004","volume":"8","author":"BA Golomb","year":"2008","unstructured":"Golomb BA, Evans MA. Statin adverse effects: a review of the literature and evidence for a mitochondrial mechanism. Am J Cardiovasc Drugs. 2008;8:373\u2013418.","journal-title":"Am J Cardiovasc Drugs"},{"key":"45_CR6","doi-asserted-by":"crossref","first-page":"581","DOI":"10.7326\/0003-4819-137-7-200210010-00009","volume":"137","author":"PS Phillips","year":"2002","unstructured":"Phillips PS, Haas RH, Bannykh S, Hathaway S, Gray NL, Kimura BJ, et al. Statin-associated myopathy with normal creatine kinase levels. Ann Intern Med. 2002;137:581\u20135.","journal-title":"Ann Intern Med"},{"key":"45_CR7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1002\/mus.20567","volume":"34","author":"GD Vladutiu","year":"2006","unstructured":"Vladutiu GD, Simmons Z, Isackson PJ, Tarnopolsky M, Peltier WL, Barboi AC, et al. Genetic risk factors associated with lipid-lowering drug-induced myopathies. Muscle Nerve. 2006;34:153\u201362.","journal-title":"Muscle Nerve"},{"key":"45_CR8","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1592\/phco.29.7.800","volume":"29","author":"MA Evans","year":"2009","unstructured":"Evans MA, Golomb BA. Statin-associated adverse cognitive effects: survey results from 171 patients. Pharmacotherapy. 2009;29:800\u201311.","journal-title":"Pharmacotherapy"},{"key":"45_CR9","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1212\/WNL.58.9.1333","volume":"58","author":"D Gaist","year":"2002","unstructured":"Gaist D, Jeppesen M, Andersen LA, Garcia Rodriguez J, Hallas J, Sindrup SH. Statins and risk of polyneuropathy: a case-control study. Neurology. 2002;58:1333\u20137.","journal-title":"Neurology."},{"key":"45_CR10","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/qjmed\/hch035","volume":"97","author":"BA Golomb","year":"2004","unstructured":"Golomb BA, Kane T, Dimsdale JE. Severe irritability associated with statin cholesterol-lowering drugs. QJM. 2004;97:229\u201335.","journal-title":"QJM"},{"key":"45_CR11","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239\u201345.","journal-title":"Clin Pharmacol Ther"},{"key":"45_CR12","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1001\/archinte.166.11.1232-b","volume":"166","author":"PS Phillips","year":"2006","unstructured":"Phillips PS, Haas RH. Observations from a statin myopathy clinic. Arch Intern Med. 2006;166:1232\u20133.","journal-title":"Arch Intern Med"},{"key":"45_CR13","first-page":"1180","volume":"172","author":"BA Golomb","year":"2012","unstructured":"Golomb BA, Evans MA, Dimsdale JE, White HL. Effects of statins on energy and fatigue with exertion: results from a randomized controlled trial. Arch Intern Med. 2012;172:1180\u20132.","journal-title":"Arch Intern Med"},{"key":"45_CR14","first-page":"AP072","volume":"127","author":"BA Golomb","year":"2013","unstructured":"Golomb BA, Koperski S. Who becomes weak on statins? Effect modification exposed in a RCT by risk factor compounding. Circulation. 2013;127:AP072.","journal-title":"Circulation."},{"key":"45_CR15","doi-asserted-by":"crossref","unstructured":"Golomb BA, Koperski S, White HL. Statins Raise Glucose Preferentially among Men who are Older and at Greater Metabolic Risk. Epidemiology and Prevention; Nutrition, Physical Activity and Metabolism 2012 Scientific Sessions; March 13\u201316, 2012; San Diego, CA.","DOI":"10.1161\/circ.125.suppl_10.A055"},{"key":"45_CR16","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.ijcard.2004.03.060","volume":"101","author":"E Karatzis","year":"2005","unstructured":"Karatzis E, Lekakis J, Papamichael C, Andreadou I, Cimponeriu A, Aznaouridis K, et al. Rapid effect of pravastatin on endothelial function and lipid peroxidation in unstable angina. Int J Cardiol. 2005;101:65\u201370.","journal-title":"Int J Cardiol"},{"key":"45_CR17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1177\/1545968305277167","volume":"19","author":"BH Dobkin","year":"2005","unstructured":"Dobkin BH. Underappreciated statin-induced myopathic weakness causes disability. Neurorehabil Neural Repair. 2005;19:259\u201363.","journal-title":"Neurorehabil Neural Repair."},{"key":"45_CR18","first-page":"6","volume":"24","author":"Adverse Drug Reactions Advisory Committee (ADRAC)","year":"2005","unstructured":"Adverse Drug Reactions Advisory Committee (ADRAC). Statins and peripheral neuropathy. Aust Advers Drug React Bull. 2005;24:6.","journal-title":"Aust Advers Drug React Bull"},{"key":"45_CR19","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1136\/jnnp.58.5.625","volume":"58","author":"T Phan","year":"1995","unstructured":"Phan T, McLeod JG, Pollard JD, Peiris O, Rohan A, Halpern JP. Peripheral neuropathy associated with simvastatin. J Neurol Neurosurg Psychiatry. 1995;58:625\u20138.","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"45_CR20","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1007\/s002280050562","volume":"54","author":"U Jeppesen","year":"1999","unstructured":"Jeppesen U, Gaist D, Smith T, Sindrup SH. Statins and peripheral neuropathy. Eur J Clin Pharmacol. 1999;54:835\u20138.","journal-title":"Eur J Clin Pharmacol"},{"key":"45_CR21","doi-asserted-by":"publisher","DOI":"10.1136\/bcr.09.2011.4758","author":"D Reilly","year":"2011","unstructured":"Reilly D, Cham S, Golomb BA. First degree relatives with behavioural adverse effects on statins. BMJ Case Rep. 2011. doi: 10.1136\/bcr.09.2011.4758 .","journal-title":"BMJ Case Rep"},{"key":"45_CR22","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s40800-015-0024-2","volume":"3","author":"S Cham","year":"2015","unstructured":"Cham S, Koslik HJ, Golomb BA. Mood, personality, and behavior changes during treatment with statins: a case series. Drug Saf Case Rep. 2015;3:1\u201313. doi: 10.1007\/s40800-015-0024-2 .","journal-title":"Drug Saf Case Rep"},{"key":"45_CR23","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2125.2003.02044.x","volume":"57","author":"H Sinzinger","year":"2004","unstructured":"Sinzinger H, O\u2019Grady J. Professional athletes suffering from familial hypercholesterolaemia rarely tolerate statin treatment because of muscular problems. Br J Clin Pharmacol. 2004;57:525\u20138.","journal-title":"Br J Clin Pharmacol"},{"key":"45_CR24","doi-asserted-by":"publisher","first-page":"1270","DOI":"10.1001\/jamainternmed.2013.14543","volume":"174","author":"BA Golomb","year":"2014","unstructured":"Golomb BA. Statins and activity: proceed with caution. JAMA Intern Med. 2014;174:1270\u20132. doi: 10.1001\/jamainternmed.2013.14543 .","journal-title":"JAMA Intern Med"},{"key":"45_CR25","first-page":"17","volume":"5","author":"S Fisher","year":"1992","unstructured":"Fisher S, Bryant SG. Postmarketing surveillance of adverse drug reactions: patient self-monitoring. J Am Board Fam Pract. 1992;5:17\u201325.","journal-title":"J Am Board Fam Pract"},{"key":"45_CR26","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/j.1875-9114.1994.tb02809.x","volume":"14","author":"S Fisher","year":"1994","unstructured":"Fisher S, Bryant SG, Kent TA, Davis JE. Patient drug attributions and postmarketing surveillance. Pharmacotherapy. 1994;14:202\u20139.","journal-title":"Pharmacotherapy"},{"key":"45_CR27","first-page":"17","volume":"127","author":"BA Golomb","year":"2013","unstructured":"Golomb BA, Koperski S. Testosterone change relates to lipid change on statins. Circulation. 2013;127:17.","journal-title":"Circulation"},{"key":"45_CR28","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0306-4530(02)00014-8","volume":"28","author":"MT Hyyppa","year":"2003","unstructured":"Hyyppa MT, Kronholm E, Virtanen A, Leino A, Jula A. Does simvastatin affect mood and steroid hormone levels in hypercholesterolemic men? A randomized double-blind trial. Psychoneuroendocrinology. 2003;28:181\u201394.","journal-title":"Psychoneuroendocrinology"}],"container-title":["Drug Safety - Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s40800-017-0045-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40800-017-0045-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s40800-017-0045-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,22]],"date-time":"2024-06-22T15:22:09Z","timestamp":1719069729000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s40800-017-0045-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,20]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["45"],"URL":"https:\/\/doi.org\/10.1007\/s40800-017-0045-0","relation":{},"ISSN":["2199-1162","2198-977X"],"issn-type":[{"value":"2199-1162","type":"print"},{"value":"2198-977X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,20]]},"article-number":"3"}}